Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12306/1604
Title: Hypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitus
Authors: Mulkah, O. Ajagun-Ogunleye
Tirwomwe, Michael
Keywords: Type 1 Diabetes Mellitus
Bidens pilosa
Diabetes
Ethno-Pharmaceutical Medicine in Uganda
Sub-Saharan Africa and Diabetes
Issue Date: Aug-2015
Publisher: Scientific Research Publishing
Citation: How to cite this paper: Ajagun-Ogunleye, M.O., Tirwomwe, M., Mitaki, R.N., Ejekwumadu, J.N., Kasozi, K.I., Pantoglou, J., Mbiydzenyuy, E.N. and Mitaki, N.B. (2015) Hypoglycemic and High Dosage Effects of Bidens pilosa in Type-1 Diabetes Mellitus. Journal of Diabetes Mellitus, 5, 146-154. http://dx.doi.org/10.4236/jdm.2015.53018
Abstract: Ethno-pharmaceutical products have received a lot of international attention in the scientific community in the management of diabetes mellitus (DM). In this study we determined the anti-diabetic and high dosage effects of Bidens pliosa in type 1 DM (T1DM). Methodology: Thirty rats were divided into six groups and subgrouped into the extract and non extract treatment groups. The extract treated group was subdivided into three groups which received 200 mg/kg, 400 mg/ kg and 800 mg/kg dosage treatments respectively. The blood glucose levels were monitored using a standard glucometer for one month, and biochemical analysis of the two liver function enzymes; Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) were carried out at the Institute of Biomedical Research (IBR-KIU-WC) at the end of week IV. The study revealed that Bidens pilosa maintained hypoglycemia for a period of two weeks and this status was lost in subsequent weeks. T1DM rats treated with a dosage of 200 mg/kg showed a better recovery (355.25 - 164.5 mg/dl) of the glucose levels, followed by those that were being treated at 400 mg/kg. The AST and ALT enzymes in blood varied with a mean ± SEM (33.72 ± 32.32 to −7.23 ± 12.61 IU and 22.98 ± 11.12 to 42 ± 38.2 IU, respectively) in both the glibencimide® and in the 800 mg/ kg treatment groups in the study. High dosages of extract were associated (P = 0.049) with increased systemic enzyme leakage. In conclusion, tissue degeneration caused by high levels of the extract was accompanied by leakage of various enzymes (AST and ALT) into the blood, which could be a major etiological factor for the development of secondary systemic pathologies, thus potentially worsening the effects of an existing T1DM prognosis in human patients.
Description: John Nnamdi Ejekwumadu, Keneth Iceland Kasozi, Julia Pantoglou, Elvis Ngala Mbiydzenyuy, Nancy Bonareri Mitaki Department of Biochemistry, Faculty of Biomedical Sciences, Kampala International University Western Campus, Bushenyi, Uganda Institute of Biomedical Research, Kampala International University Western Campus, Bushenyi, Uganda Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Bushenyi, Uganda
URI: http://hdl.handle.net/20.500.12306/1604
Appears in Collections:Department of Biochemistry

Files in This Item:
File Description SizeFormat 
Hypoglycaemic Effect of Lycopene in Streptozotocin-Induced Diabetic Wistar.pdfFull text518.47 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.